Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-04 12:39 pm Purchase | 2025-04-01 | 13G | Mereo BioPharma Group plc MREO | Frazier Life Sciences Public Fund, L.P. | 40,349,315 5.100% | 40,349,315 (New Position) | Filing History |
| 2025-02-14 11:27 am Sale | 2025-01-31 | 13G | AnaptysBio, Inc. ANAB | Frazier Life Sciences Public Fund, L.P. | 463,241 1.500% | -1,192,054 (-72.01%) | Filing History |
| 2025-02-14 11:25 am Sale | 2024-12-31 | 13G | AnaptysBio, Inc. ANAB | Frazier Life Sciences Public Fund, L.P. | 1,655,295 5.400% | -261,896 (-13.66%) | Filing History |
| 2025-02-14 11:22 am Sale | 2024-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Frazier Life Sciences Public Fund, L.P. | 1,176,735 2.000% | -2,384,909 (-66.96%) | Filing History |
| 2025-02-14 11:21 am Purchase | 2024-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Frazier Life Sciences Public Fund, L.P. | 10,664,774 11.900% | 3,283,684 (+44.49%) | Filing History |
| 2025-02-14 11:11 am Sale | 2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -2,631,713 (Position Closed) | Filing History |
| 2025-02-14 11:07 am Unchanged | 2024-12-31 | 13G | AN2 Therapeutics, Inc. ANTX | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-02-10 10:55 am Purchase | 2025-02-03 | 13G | Maze Therapeutics, Inc. MAZE | Frazier Life Sciences Public Fund, L.P. | 3,193,900 7.300% | 3,193,900 (New Position) | Filing History |
| 2025-01-08 3:04 pm Purchase | 2024-12-13 | 13G | Palvella Therapeutics, Inc. PVLA | Frazier Life Sciences Public Fund, L.P. | 575,892 5.100% | 575,892 (New Position) | Filing History |
| 2024-11-27 11:01 am Purchase | 2024-11-20 | 13G | Savara Inc. SVRA | Frazier Life Sciences Public Fund, L.P. | 8,660,379 5.000% | 8,660,379 (New Position) | Filing History |
| 2024-11-20 10:44 am Purchase | 2024-11-14 | 13G | MacroGenics, Inc. MGNX | Frazier Life Sciences Public Fund, L.P. | 3,175,665 5.100% | 3,175,665 (New Position) | Filing History |
| 2024-11-07 2:34 pm Purchase | 2024-11-05 | 13D | KalVista Pharmaceuticals, Inc. KALV | Frazier Life Sciences Public Fund, L.P. | 4,887,867 10.000% | 1,200,000 (+32.54%) | Filing History |
| 2024-11-06 10:30 am Purchase | 2024-09-30 | 13G | Trevi Therapeutics, Inc. TRVI | Frazier Life Sciences Public Fund, L.P. | 7,381,090 10.200% | 717,500 (+10.77%) | Filing History |
| 2024-11-05 11:44 am Purchase | 2024-10-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Frazier Life Sciences Public Fund, L.P. | 3,561,644 6.100% | 3,561,644 (New Position) | Filing History |
| 2024-09-23 10:48 am Purchase | 2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX | Frazier Life Sciences Public Fund, L.P. | 5,985,347 18.800% | 5,985,347 (New Position) | Filing History |
| 2024-08-22 4:05 pm Purchase | 2024-08-20 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 12,788,710 18.000% | 2,618,922 (+25.75%) | Filing History |
| 2024-07-15 1:17 pm Purchase | 2024-07-11 | 13G | Elevation Oncology, Inc. ELEV | Frazier Life Sciences Public Fund, L.P. | 5,993,579 11.000% | 3,035,000 (+102.58%) | Filing History |
| 2024-06-25 10:06 am Purchase | 2024-06-17 | 13G | Disc Medicine, Inc. IRON | Frazier Life Sciences Public Fund, L.P. | 1,754,834 5.900% | 1,754,834 (New Position) | Filing History |
| 2024-06-06 1:59 pm Purchase | 2024-03-07 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 10,169,788 17.400% | 44,000 (+0.43%) | Filing History |
| 2024-05-31 2:00 pm Purchase | 2024-05-29 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund, L.P. | 10,639,562 21.400% | 833,090 (+8.50%) | Filing History |